07:50 AM EDT, 09/11/2024 (MT Newswires) -- Bausch Health Companies ( BHC ) said Wednesday that Health Canada approved its Cabtreo topical gel as treatment for acne vulgaris in patients at least 12 years old.

Cabtreo is the first Health Canada-approved "triple-combination" topical treatment for acne, Bausch said.

The treatment will be available in pharmacies across Canada in Q4, the company said.

Price: 6.37, Change: +0.12, Percent Change: +1.92